Eli Lilly sues two compounders over tirzepatide after FDA lifts Zepbound, Mounjaro shortage status in key GLP-1 legal test.
An international research group led by the Helmholtz Center for Infection Research (HZI) has discovered a promising new drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback